Impact of age on the prognostic value of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: Insights from the British cardiovascular intervention society

Around one third of patients undergoing percutaneous coronary intervention (PCI) have left ventricular (LV) dysfunction. Whilst the prevalence of LV dysfunction is known to increase with age, the prevalence of LV dysfunction in different age groups in the PCI setting is not known and the effect of age on the prognostic value of LV function in the PCI setting has not been examined.

[1]  S. Silber,et al.  The influence of age on clinical outcomes in patients treated with the resolute zotarolimus‐eluting stent , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  S. Anderson,et al.  Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society. , 2014, European heart journal.

[3]  S. Anderson,et al.  Arterial access site utilization in cardiogenic shock in the United Kingdom: is radial access feasible? , 2014, American heart journal.

[4]  Samin K. Sharma,et al.  Risk Stratification for Long-Term Mortality After Percutaneous Coronary Intervention , 2014, Circulation. Cardiovascular interventions.

[5]  F. Eberli,et al.  Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012 , 2013, Heart.

[6]  E. Peterson,et al.  Temporal trends in percutaneous coronary intervention outcomes among older patients in the United States. , 2013, American heart journal.

[7]  David Dai,et al.  Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry). , 2013, JACC. Cardiovascular interventions.

[8]  Helen Routledge,et al.  Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice? , 2013, JACC. Cardiovascular interventions.

[9]  G. Stone,et al.  Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial). , 2013, The American journal of cardiology.

[10]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[11]  E. Steyerberg,et al.  Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. , 2012, European heart journal.

[12]  T. Kirkwood,et al.  Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study , 2012, Heart.

[13]  J. Spertus,et al.  Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention. , 2012, The American journal of cardiology.

[14]  D. Perera,et al.  Does left ventricular function continue to influence mortality following contemporary percutaneous coronary intervention? , 2012, Coronary artery disease.

[15]  Mario J. Garcia,et al.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, The Journal of thoracic and cardiovascular surgery.

[16]  K. Kent,et al.  Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction. , 2012, American Journal of Cardiology.

[17]  D. Faxon,et al.  Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). , 2012, The American journal of cardiology.

[18]  J. Spertus,et al.  Influence of Frailty and Health Status on Outcomes in Patients With Coronary Disease Undergoing Percutaneous Revascularization , 2011, Circulation. Cardiovascular quality and outcomes.

[19]  P. Ludman.  British Cardiovascular Intervention Society Registry for audit and quality assessment of percutaneous coronary interventions in the United Kingdom , 2011, Heart.

[20]  P. Serruys,et al.  Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  Volkmar Falk,et al.  Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .

[22]  Elizabeth R DeLong,et al.  Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. , 2010, Journal of the American College of Cardiology.

[23]  J. Berger,et al.  Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention. , 2009, The American journal of cardiology.

[24]  A. Jacobs,et al.  The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry. , 2006, American heart journal.

[25]  K. Detre,et al.  Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions or=50% having percutaneous coronary revascularization. , 2003, The American journal of cardiology.

[26]  R. Lancashire,et al.  Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study , 2001, The Lancet.

[27]  A Hofman,et al.  Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. , 1999, European heart journal.

[28]  J. Cuzick.  A Wilcoxon-type test for trend. , 1985, Statistics in medicine.